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In the world of cell biology, many processes are controlled by small GTPases. In all cells, but especially in the highly motile lymphocytes, the regulation of actin and integrins is important to control the function of the cells. Lymphocytes consist of two types; B- and T-cells. B-lymphocytes are involved in the humeral response to pathogens. T-lymphocytes play an important role in the cellular attack of pathogens, like bacteria and viruses. When such a pathogen breaches the mechanical barriers between the environment and the inside of the body, lymphocytes migrate to the place of infection to cause an inflammation that destroys the intruder. For the process of migration and cell movement in general, activation and inactivation of small GTPases is important. They are considered to be an evolutionary conserved, regulatory switch, with their activity being controlled by GEFs and GAPs (Bourne H. R. et al., 1990). Additionally, GTPases play an important role in the deregulation of cancer cells. Metastasis and tissue invasion are what makes cancers malignant. In these processes, movement and adhesion play key roles, which are modulated by the small GTPase Rap.


In which processes are different GTPases playing a role?

GTPases are molecular switches that control the on or off state of a specific pathway. The on or off state depends on the binding or hydrolysis of GTP, respectively. Guanine exchange factors (GEFs) and GTPase activating proteins (GAPs) are responsible for this process, respectively. For each GTPase there are specific, and sometime multiple, sets of these GEFs and GAPs. Many signaling pathways make use of GTPases, and the number of newly discovered pathways is still growing (Bourne H. R. et al., 1990). In normal conditions, GDP and GTP have the same affinity for GTPases. When a GEF is bound to a GTPase, GDP releases due to conformational changes and GTP binds in the same binding domain, but in a slightly different way. It binds in a slightly different way, because GTP has to ignore the changes in the GDP binding site and still bind to the GTPase (Bos J. L. et al., 2007). Below, three of the most important GTPase families are listed.

Ras, Rho and Rab; Regulators of cell movement and proliferation
One of the biggest and most known groups of GTPases is Ras, which is part of the proto-oncogenic Ras-superfamily.  In mammals, three types of Ras (H-Ras, K-Ras and N-Ras) are responsible for a controlled cell proliferation and differentiation. Oncogenic point mutations in the Ras gene can result in the inability of the GAP to hydrolyze the GTP, bound to the GTPase. However, the GAP is still able to bind the GTPase. All in all, these mutations lead to constitutive activation of Ras and over time causes neoplasms (Bourne H. R. et al., 1990). Rap1 and Rap2 proteins are members of the Ras-GTPase-family.
To align the dividing cell correctly, members of the Rho family GTPases are activated. Rho is activated through extracellular signals. Nowadays, 80 RhoGEFs and over 100 RhoGAPs are known. Effectors and also binders of Rho act on the building of actin filaments by actin polarization. As Rho influences the actin filaments, the activation of Rho also leads to cell cycle entry and progression, by inducing mitosis. Actin filaments are necessary to form the mitotic spindle by connecting the microtubules to the kinetocores. Later on, actin is also involved in the contractile ring formation, which is necessary for the separation of daughter cells (David M. et al., 2012). 
The Rho family is also involved in cell migration as well as cell division. One member of the Rho GTPase family is Rac, which is involved in reorganization of the cytoskeleton and cell division. Rac deficient macrophages have impaired ability to migrate to the site of infection, which means that Rac is also an important player in cytoskeleton regulation (Aflaki E. et al., 2011).  Recently, new discoveries about Rac were made; during motisis, Rac and its effectors ensures cell division at the division plane by constriction of the contractile ring (Davies T. and Canman J. C., 2012). 
Cdc42 is also a family member of the Rho GTPases. Cdc42 is a key player in chemotaxis of neutrophils. For chemotaxis, neutrophils are controlled by cell polarization, in which cdc42 is described to be involved via its effector WASp. When activated, WASp localizes to the plasma membrane and regulates the CD11b integrin for cell polarization (Kumar S. et al., 2012).

The Rap family of GTPases 
Rap1, a Ras homology sharing protein, is a GTPase, which was first found to be capable of reverting the morphological phenotype of Ras-transformed fibroblasts (Kitayama (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed?term=Kitayama%20H%5BAuthor%5D&cauthor=true&cauthor_uid=2642744​) H. et al., 1989), but over time Rap1 was discovered to be involved in many different processes, varying from regulating angiogenesis to roles in the cardiovasculature. It was discovered that Rap1 is an evolutionary conserved protein important in morphogenesis. Rap1 consists of two closely related isoforms; Rap1a and Rap1b. Also, Rap2 is discovered to be an important GTPase in several overlapping signaling pathways. It is remarkable that some functions are different, although Rap1 and 2 share homology of 60%. For example, Rap2, but not Rap1, is involved in the vesiculation in erythrocytes (Greco F. et al., 2006). Rap2 is considered to be a slower GTPase switch in Rap1 signaling pathways (Ohba Y. et al.,  2000). In this review, the role of Rap1 in the process of cell-cell junction formation and adhesion of cells is discussed.

Regulation of the Rap family of GTPases – GAPs and GEFs

GEFs activate Rap1 by replacing GDP for GTP
Rap1 proteins are activated by several external stimuli through the special and temporal control of the GEFs and GAPs, which activate the protein (Bos J. L., 2005). As described before, GEFs are needed to activate GTPases. There are at least five different classes of GEFs known; C3G (RapGEF1), PDZ-GEF1 and-2 (RapGEF2 and 6), Epac1,-2 and Repac (RapGEF3, 4 and 5), CalDAGGEF1 (RasGRP2) and Dock4 (Fig. 1). A selection is explained below.
C3G was the first discovered as a RapGEF. It contains a characteristic catalytic domain and a specific Ras exchange motif (REM). This was proven similar to the already known RasGEF CDC25 (Hogan C. et al., 2004). Nowadays, there are three pathways known to activate C3G; engagement of nectins, extracellular signals like hormones that act on (non-)receptor tyrosine kinases or activation by stretching due to mechanical stress of the cell membrane. Nectins are immunoglobulin-like transmembrane proteins that form dimers with nectins on adjacent cells or the extracellular matrix to form focal adhesions. Activation of a nectin leads to binding of the Src protein to the intracellular domain of the nectin, which causes recruitment and activation of C3G (Pannekoek W. J. et al., 2009). One example of a receptor tyrosine kinase is IGF-I. When activated, IGF-I activates Src (Giannoni E. et al., 2005). Activated Src activates, in turn, the C3G RapGEF.
	A second RapGEF that activates Rap1 his is the exchange protein directly activated by cAMP (Epac). Epac shares structural homology with C3G and is thereby believed to be able to activate Rap1 directly. As the name implies, Epac becomes activated by cyclic adenosine monophosphate  (cAMP). In vitro tests have pointed out that when cAMP was added to a mixture of Epac and Rap1, Rap1 was activated (Rooij de J. et al., 1998). When the G-protein coupled receptor (GPCR) gets activated by an external signal the intercellular Gs domain of the receptor, in turn, activates an adenylyl cyclase enzyme. The adenylyl cyclase catalyzes the conversion of ATP to cAMP (Janoune J. and Defer N., 2001). Rooij de J. et al., (1998) found that Epac has a great structural homology with cAMP binding proteins, like PKA. A specific alanine in the cAMP binding site of Epac proved to be important for specific binding of cAMP and not to cGMP for example. 
Dock4 is a RapGEF, which is important in the activation of Rap1 in cell-cell junction formation. In which cell-cell junction construction remains unclear, but making a knock down of the DOCK4 protein results in less adhesion in neighboring cells (Kooistra M. R. H. et al., 2007). Interestingly, Dock4 is activated by another GTPase; RhoG. How Rho is activated remains unclear, but it was shown that this process directly correlates with metastatic properties of breast cancer cells (Hiramoto-Yamaki N. et al., 2010).

GTPases are inactivated by the hydrolyzing activity of RapGAPs
When a GAP binds to a GTPase, a water molecule lines up for an attack on the leaving phosphate group of the GTP. The effectiveness of the attack depends on the in-line attack, the polarization of the water molecule and the stable interaction of GDP and GTPase that the GAP leaves behind (Bos J. L. et al., 2007). For Rap1, there are several GAPs known, for instance CAPRI, RASAL and GAP1P4BP (Fig. 1), which are all members of the GAP1 family of RasGAPs. Thus, GAPs from the Gap1 family are both capable to interact with Rap1, as well with Ras. This requires an extra level of regulation to switch between the GAP induced inactivation of Ras and Rap GTPases (Gloerich M. and Bos J. L., 2011). 
	CAPRI and Rasal are both, despite their structural homology, regulated differently under influence of Ca2+. When Ca2+ is released from the endoplasmic reticulum, Rasal translocates to the plasma membrane in a repetitively oscillating way, dependent on the Ca2+-concentrations. CAPRI stays bound to the plasma membrane for a longer period, independent of fluctuations of the Ca2+-concentrations, once the threshold is reached (Liu Q. et al., 2005). Once at the plasma membrane, CAPRI can hydrolyse Rap-bound GTP and by this deactivate the GTPase. This localization is important because Rap and Ras, when active, are also plasma membrane bound proteins (Bivona T. G. and Philips M. R., 2003). When exposed to Ca2+, CAPRI forms homodimers. It has been found that mutations in the dimer-forming region blocks the formation of dimers but CAPRI is still activated by translocation to the cell membrane. When compared to the wild-type monomers, which still are able to form dimers, the mutant monomers seem to have a higher RasGAP activity, while the wildtype monomers had a higher RapGAP activity (Dai Y. et al., 2011). Rasal switches between the Ras and Rap GAP activity in a different way. Data has suggested that Rasal RapGAP activity, in contrast with CAPRI, is present when it is located in the cytosol in the process of switching back and forth with the plasma membrane, as mentioned above. When located at the plasma membrane the activity of Rasal switches to RasGAP activity. (Kupzig S. et al., 2006 and Sot. B. et al., 2010).


Biological processes controlled by Rap1 (general bit)

Actin is involved in processes of cell movement 
The cytoskeleton gives structure to cells, similar to the bone and cartilage structures of the human body. It consists of three structures; microtubles, intermediate filaments and the microfilaments (or actin filaments). They give shape to the cell and the localization of cellular organelles depend on it. Microtubles form central building blocks around the nucleus, while the actin filaments are the connecting cables, which are more present throughout the cell. The highly dynamic actin filaments regulate cell shape by pushing mechanically against the cell membrane (Troys van M. et al., 2008). Also, migration is regulated similarly. The pushing actin filaments cause specific protrusions of the membrane at the site of direction where the cell is migrating to. Some cells make use of formation of small filopodia, pointy bulges which consist of actin in combination with bundling proteins. But for migration cells extent broader, thin, sheet like lamellipodia. Lamillipodia form the leading edge of the moving cell boarder (Khurana S. and George S. P., 2011 and Sheetz M. P. et al., 1992). Moreover, membrane protrusion by the actin cytoskeleton, in conjunction with myosin proteins,  is not only involved in cell migration, but also chemotaxis (Lee M. R. and Jeon T. J., 2012), processes such and endocytosis and phagocytosis (Mooren O. L. et al., 2012), and the cell cycle. Within the process of the cell cycle, the actin cytoskeleton ensures both mitosis and chromosome alignment, which are essential for daughter cell survival (David M. et al., 2012). All in all, actin is important in many processes of cell movement regulation. As a consequence, malfunction of actin can lead to disrupted cell movement and plays a critical role in the progression of disease. This is especially important in cancer cell metastasis. For this process of dissemination, the actin cytoskeleton forms the basis for directed cell migration (Bravo-Cordero J. J. et al., 2012). Since Rap1 is one of the regulators of actin, it is considered one of the regulatory causes of cancer cell metastasis.
Below are listed the trans-cellular bridges where the actin filaments of adjacent cells by which they are connected. These bridges are tight junctions, adherence junctions and focal adhesions.

Cell-ECM adhesion processes (Focal adhesions connect with actin) 
In the development of organs and tissues, cells have to align in the right order and polarize to form a working mechanism. Cells start to bind mechanically to the extracellular matrix by forming focal adhesions. Focal adhesions are assembled by specialized integrins that interact with fibronectin. The actin-rich areas of the cell, like filopodia, scan their surroundings for possible attachments sites and/or migration pathways. While doing this, reversible interactions with the extracellular matrix take place. Localization and anchoring of epithelial cells depends on the interaction between integrins and components of the basement membrane, such as collagen fibers in the basement membrane (Yeh Y. C. et al., 2012). Furthermore, it has also been shown that integrins are involved in the correct polarization and differentiation in epithelial cells of the mammary gland (Faraldo M. M. et al., 1998). When an integrin binds to fibronectin, using its integrin receptor, it gets activated. While activated, integrins recruit several actin-binding proteins, including talin. Besides being the adaptor between integrins and the actin cytoskeleton, talin ensures integrin clustering. Clustering of integrins is directionally proportional to the binding strength  (Wehrle-Haller B., 2012). Also, it has been found that there cross-talk between integrins, Src and Rho signalling exists. When integrins are activated, Src will bind and activates the GTPase Rho signalling pathway, by recruitment of RhoGEFs (Huveneers S. and Danen E. H., 2009). Also other GTPases are activated this way. In lymphocytes, integrin LFA-1 activation will activate Rho, but also Rap1 via Src. Activation of both pathways contribute to cell migration (Mor A. et al., 2007).

Cell-cell adhesion processes 
Cell-cell junction formation is important for the localization of cells in the formation of organs and tissues, like blood vessels. In more tightly structured cell types, like the epithelium barriers in many organs, no fluid, proteins, molecules or cells must pass uncontrolled. Cell-cell adhesion is induced by structures, termed tight junctions and adherens junctions, and, as well as promoting tissue integrity, these structures are important for preventing the unregulated entry of substances into tissues.  Furthermore, cell junction formation is a mechanism by which cell polarity may be established (Price L. S. et al., 2004). 
	The two most important components of tight junctions are occlodin and claudin. Occlodins are localized to tight junctions that are under construction by phosphorylation by the epithelial cells. When arrived they undergo a tight interaction with claudin and JAM1 on adjacent cells to form a tight junction protein complex (Hartsock A. and Nelson W. J., 2008). Moreover, it is also described that claudins on their own are involved in occludin localization (Furuse M. et al., 1998). While Rap1 is not directly involved in the formation of tight junctions it has been found that association between tight- and adherens junctions, however, is regulated by Rap1. It has been discovered that, using immuno-fluorescence microscopy, knock down of Rap1 resulted in diminished levels of adherens and tight junction association (Birukova A. A. et al., 2011).
	Cell-cell adherens junctions are based on the cadherin-cadherin linkage between adjacent epithelial cells. E-cadherins are trans-membrane glycoproteins and the most important molecules in cell-cell adhesion. The cadherin interaction is highly dynamic and when cadherins production is lost, cell-cell adhesion is impaired and can lead to many diseases, such as cancer metastasis. The extracellular domain of E-cadherins undergoes Ca2+-dependent conformational changes and extension of the integrin takes place, so interaction can take place. The intercellular domain is linked to the actin cytoskeleton by catenin anchor proteins.  (Hartsock A. and Nelson W. J., 2008). 
	Rap1 is potentially a key player in mediating the cell-cell adherens junction formation. Knox A. L. and Brown N. H. demonstrated in 2002 that knockdown of Rap1 in epithelial cells in vitro caused disposition of the adherens junctions. They all distributed to one side of the cell. The same authors stated that Rap1-induced migration is based on tight collaboration between the cadherins of the adherence junctions and the actin cytoskeleton. The activation of cadherins, and also integrins, is not only described in the process of migration over endothelial cells but recent studies have determined that Rap1 activation also plays a role in the mechanism of adhesion and cell-cell junction formation in the cardio vasculature (Jeyaraj S. C. et al., 2011). Rap1 may be involved in the formation of adherens junctions, it is, however, not involved in sustaining them (Hogan C. et al., 2004)  Cell-cell junction breakdown is one of the steps in the epithelial-to-mesenchymal transition which is required for cancer cells to become invasive and leave the primary tumor site. Expression of constructively active Rap1 reversed Ras induced tumor cell phenotype of endothelial cells, by promoting the grouping of cells, thus lowering their metastatic potential (Price L. S. et al., 2004). In addition, activation of cadherins leads to activation of more cadherins. C3G is able to interact with, and is activated by, the intercellular domain of cadherins. C3G uses its Rap1GEF activity to activate Rap1. Rap1 ensures for cadherins localization to the adherence junctions again to maintain cell adhesion. Thus, Rap1 is part of a positive feedback loop. (Hogan C. et al., 2004 and Citi S. et al., 2011). Regulation of adherens junctions also contributes to polarity that maintains tissue integrity. In human breast epithelial cells Rap1 is found to be responsible for apical-basal polarity (Itoh M. et al., 2007). Next, it was discovered that adherens junctions play a role in the mechanical maintaining of polarity (Huang J. et al., 2011). Because, Rap1 is important for adherence junction formation, this suggests that Rap1 is ensuring polarity for tissue integrity by forming and localizing adherence junctions.

Rap-mediated adhesion processes and their implication for immune cells and Leukemia
Rap1 is mostly known for regulation of adhesion activity via integrins. Integrins act on the actin cytoskeleton and are able to bind to other cells, as well to the extracellular matrix. Cell-cell and cell-ECM adhesion formation are important processes when it comes down to cell localization and anchoring to the basement membrane or extracellular matrix. Rap1 does this by localization of the integrins to the cell surface (Boettner B. et al., 2009). However, tight regulation of Rap-mediated adhesion is essential for a correct biological response. Wittchen E. S. et al described in 2005 that prolonged activation of Rap1 inhibited the transmigration of leukocytes, because of the strong adhesion to endothelial cells. Moreover, leukocyte transmigration was also inhibited when Rap1 was upregulated in the endothelial cells. This declares a direct link between Rap1 and integrin activity. 
	Integrin localization is needed for migration over the endothelial cell layer of the blood vessels for instance. For this, fast travelling immune cells have first to slow down using integrin adhesion. When an infection arises, these cells migrate out of the bloodstream, located near the infection. For this, adhesion has to be activated for a short period of time. 
In leukemias, cell adhesion promotes metastasis, and regulation of Rap1, therefore is of potential importance. Leukemic cells can take advantage of this adhesion process (Kawauchi T., 2012). For instance, when these cells are able to activate Rap1 randomly, metastasis is an easy achievement. For this, cancer cells have also to find ways to re-deactivate the adhesion process again, in order also to stop epithelial binding. So, cells can detach again and continue on their way.
	All in all, integrins are involved in many structural and migration processes of several cell types, most of them are regulated by Rap1. Therefore, we have speculated that defects in one of the Rap1 pathways could result in diversity of diseases. 


Rap effector proteins and their function 

The ability of active Rap1 to regulate the diverse range of cellular processes described above is mediated in part by the multitude of GEFs and GAPs that act on Rap, but also by the range of different effector proteins. The most important effectors include Afadin (AF-6), Krit, RAPL, Riam, Radil, Ezrin, Arap3 and Tiam/Vav (Raaijmakers J. H. and Bos J. L., 2009). Most of these effectors are presented in figure 6.

Effectors in cell-cell adhesion
Afadin binds directly to the Ras associating domain of Rap with high affinity. Activation of Afadin leads to changes in tight junctions and adherence junctions. Both junctions consist inter alia of cadherins and catenins protein complexes, in which catenins connect the cadherins to the cytoskeleton. Afadin contains a PDZ domain, which interacts to p120 catenin to prevent cadherin internalization. This strengthens the junctions, because the more molecules, the more solid connections between cells exist. Moreover, Afadin can bind to and activate ZO-1, which links the tight junctions to the actin cytoskeleton (Ebnett K. et al., 2000). A third role of Afadin is that it can act as a scaffold protein helping the interaction of nectins and the actin cytoskeleton in adhesion junctions (Fig. 2) (Ebnett K., 2008). Nectins are immunoglobulin proteins which can bind trans-homophilic and trans-heterophilic to nectins of adjacent cells. Also, Afadin recruits a specific active RapGAP, which is involved in the negative feedback loop on Rap (Bos J. L., 2005). 














	Ezrin is a rap1 effector, which is involved in another type of cytoskeleton regulation, namely cell spreading. Cell spreading is the integrin-initiating process where cells flatten out in an adhesive environment like the ECM. During this process the cells deform drastically. In this process the actin cytoskeleton expands greatly, by which the cell in every direction in a 2 dimensional way (Cuvelier D. et al., 2007). The reason why cells spread is still not entirely known, but it is known, however, that in cancer cell lines this process is also detected (Ross S. H. et al., 2011). Ezrin is found to be a downstream factor of active Rap1. In tests with A549-Epac1 cells, but also in other cell lines, in which a Ezrin knockdown was introduced with siRNA, cell spreading was decreased significantly. Moreover, when Ezrin was re-introduced in these cells, the process of cell spreading was restored. This confirmed the results that Ezrin is the responsible factor (Ross S. H. et al., 2011).




Rap1 effectors important in T-cells: RIAM and RAPL
RIAM and RAPL are both involved in integrin regulation, particular in leukocytes and lymphocytes. Integrins interact with adhesion molecules on endothelial cells like ICAM-1 in order to migrate over this cell barrier.

Intermezzo; The biological role of RIAM, an effector protein of Rap1

Introduction
The Rap1 isotopes 1a and 1b are, like all other GTPases, going through a continuous cycle of two states; the inactivating GDP bound state and the activating GTP bound state (Bos J. L. et al., 2007). When present in the GTP bound state, Rap1 activates several effector proteins, which are mainly involved in a broad spectrum of actin dynamics. Since Rap1 is located at the plasma membrane using its C-terminal CAAX box (Lee H. S. et al., 2009) activation takes place here.
	One group of the members of the MRL (Mig-10/RIAM/Lpd) adaptor protein family are Rap1-GTP interacting adapter molecules (RIAMs). These molecules are defined as a set of effector proteins of the active Rap1 GTPase. For this, the RIAM family is consisting of two specific domains involved in binding of Rap1 and several proline-rich areas in their primary amino acid sequence. Overexpression and knockdown studies of RIAM showed that it is involved in processes that require actin polymerization, like cell spreading, cell adhesion and homeostasis (Lafuente E. M. et al., 2004 and Bivona T. G. et al., 2004).

Activation of RIAM
Consequences of knockdown and overexpression of RIAM showed the importance of this Rap1 effector in actin dynamics. For instance, overexpressing RIAM in HEK293 cells or Jurkat T-cells, induced clear cell spreading and lamellipodia formation compared to the control cells. Also, RIAM transfected in the same cells showed a 4 to 5 times higher cell adhesion to adjacent cells (Lafuente E. M. et al., 2004). To confirm, overexpression of RIAM in T-cells increased the adhesion to fibronectin and ICAM (Ménaché G. et al., 2007). In contrast, knockdown of RIAM did not result in lamellipodia formation and cell spreading (Lafuente E. M. et al., 2004), nor the increase of cell-cell adhesion formation (Ménaché G. et al., 2007).
The exact activation of RIAM is still poorly understood. Known is that, since activated Rap1 is located at the plasma membrane, RIAM co-localizes with Rap1 at this location (Lee H. S. et al., 2009). This process is facilitated by specific domains of RIAM. RIAM consists of two binding domains. One domain, the Ras association (RA) domain, forms an interaction with the Rap1-GTP. The other, named pleckstrin homology (PH) domain, stabilizes this interaction (Takala H. and Ylänne J., 2012). When at the plasma membrane, RIAM forms an adaptor protein between Rap1-GTP and downstream proteins, which are involved in actin dynamics and integrin activation (Fig. 3).

Biological effects of Rap1-RIAM adaptor complexes
Actin regulation by RIAM
As a scaffold protein, RIAM binds to and colocalizes with a wide variety of proteins, of which a selection is described here. When bound to Rap1-GTP six putative proline-rich areas, which are profilin-specific binding areas, of RIAM are exposed for interaction. Profilin enhances the exchange of actin-ADP to actin-ATP monomers and are pooled. Actin-ATP monomers are ready to be build in for prolongation of the actin strand, which is a general need for cell motility of any kind (Pollard T. D. and Borisy G. G., 2003). Together with profilin, also ENA/VASP protein family members are interacting with the proline-rich areas of RIAM, which are enhancing actin polymerization (Lafuente E. M. et al., 2004). After binding to RIAM, proteins of the ENA/VASP family inhibit the actin capping protein CapZ. Active capping proteins prevent the prolongation of actin multimers (Kraus M. et al., 2003). To support the interaction of RIAM with Profilin and ENA/VASP, Lafuente E. M. et al. also showed that RIAM and F-actin are colocalizing at the leading edge of actin polymerization. RIAM and F-actin antibodies were used in RIAM transfected cells to test this. This leads to lamellipodia formation and cell spreading in RIAM over-expressing cells.
	
RIAMs involvement in cell-cell adhesion
Furthermore, RIAM is involved in cell-cell adhesion processes. This is regulated through a RIAM-induced protein complex, which ultimately results in the activation of β1 and β2 integrins. This protein complex consists of Rap1, RIAM, β1 or β2 integrin and a protein called talin. Talin is bound by a N-terminal 103-residue fragment of RIAM and both interactions with Rap1 and talin are needed for integrin activation. How Talin interacts and activates integrins is still largely unknown. But it does explain the increased cell adhesion when RIAM was overexpressed in Jurkat T-cells. Also here, these findings were supported by colocalization studies of RIAM and integrins. Indeed, RIAM colocalizes with β1 and β2 integrins (Lee H. S. et al., 2009). Lee H. S. et al. also discovered that Rap1 activation could be bypassed if they expressed a recombinantly made RIAM-(1-176), which lacks the Rap1 binding site, with an integrated CAAX domain. They saw that RIAM-(1-176) still colocalized with talin at the plasma membrane. Moreover, in these settings, integrins were still activated as well. This indicates that localization of talin to the plasma membrane is enough to activate integrins, independently of activation of Rap1. However, integrin activation by talin is not independent of RIAM-talin interaction. This makes the downstream role of RIAM in relation to Rap1 clear as already described by Lafuente E. M. et al. and the increased cell adhesion in RIAM transfected cells. The higher activation of RIAM, the higher stimulation of talin-dependent integrin activation. In contrast, when RIAM knockdown is introduced, talin activation was strongly inhibited (Watanabe N. et al., 2008).
	Another way in which RIAM is involved in integrin activation, is linking Rap1-GTP to ADAP (adhesion and degranulation-promoting adapter protein) and SKAP-55 (55-kDa src kinase-associated phosphoprotein) proteins. The ADAP/SKAP-55 module is important for T-cell receptor mediated integrin activation by a process which is called inside-out signaling. Using immunoprecipitation studies, it was found that only SKAP-55 binds to both the RIAM RA and PH domains separately and forms a trimolecular complex with ADAP. Since it is already known that ADAP also associates with VASP and profilin (Griffiths E. K. and Penninger J. M., 2002), there is speculated positively about two overlapping pathways involved in actin polymerization and integrin activation. This could be a plausible hypothesis, since the activation of integrins and the induction of actin polymerization are simultaneously needed for cell migration. These speculations are supported by RNAi assays against SKAP-55, which revealed an impaired T-cell adhesion (Ménaché G. et al., 2007).

RIAM stabilizes the localization of Rap1-GTP at the plasma membrane 






























The other integrin activating Rap-effector in T-lymphocytes is RAPL. RAPL activation starts with the stimulation of the T-cell receptor by chemokines. When activated, RAPL binds, together with the Mst1 kinase to the specific integrin LFA-1, which gets activated (Fig. 5) (Raaijmakers J. H. and Bos J. L., 2009). After activation, LFA-1 is relocated to the leading edge to bind to ICAM-1 on endothelial cells. This interaction forms a strong bond for leukocytes and lymphocytes in diapedesis. It has been demonstrated that RAPL knock-out lymphocytes and macrophages lack the ability the bind ICAM-1 molecules with LFA-1 integrins. Moreover, distribution of integrins is defective after treatment with cytokines, and so these cells have impaired adhesion and migration (Katagiri K. et al., 2004).
















Rap effectors involved in other GTPase signaling pathways: Arap3 and Tiam1/Vav2
Finally, I would like to introduce two Rap effectors which play a critical role in other GTPase signaling pathways, concerning cell-cell junction formation and migration; Arap3 and Tiam1/Vav2.
Arap3 is a Rap-induced GAP for the Rho GTPase family. Rho is, like Rap, involved in many adhesion and migration processes, through its regulation of the actin cytoskeleton. When Arap3 is added to cells Rho is more present in its GDP bound state and ensures actin demolition. So, Rap1 is also involved in not only activation of the prolongation of actin but also in reducing actin. Since Rho is also important in regulated destruction of the actin skeleton, disruption of Arap3 causes problems at the site of direction where the cell is migrating to, as well at the site where it is migrating away from. In other words, the Rap1/Arap3 pathway is important for actin clearance (Krugmann S. et al., 2004). 
The second group of Rap-effectors which are involved in regulation of other GTPases is Tiam1/Vav2. These proteins interact with the Rac GTPase, which is involved in actin regulation (Fig. 6). It was one of the first pathways known in Rap dependent actin regulation. Tiam1 and Vav2 are both RacGEFs, which results in co-activation of Rac when Rap is in its GTP bound state (Bos J. L., 2005). By binding Rap, Tiam1/Vav2 are located at the plasma membrane, the location were they bind to and activate Rac. It has been discovered that activation of Rap causes cell spreading and lamellipodia formation, which indicates the Rac activation must have occurred (Arthur W. T. et al., 2004). 




















The pathology of Leukemia and lymphomas

Cancer is defined as the disease of uncontrolled cell growth that induces diseased cells to spread to other tissues or organs to start directed invasion, called metastasis. In order to achieve this uncontrolled growth a cell has to undergo several mutational changes that allow cells to sustain proliferative signaling, evade growth suppressors, resist cell death, inducing angiogenesis, enabling replicative immortality and activating invasion and metastasis. These last two characteristics are where the function of Rap1 becomes important in disease progression. Cancer can arise from every tissue type, so also from white blood cells. Leukemia is the overarching name for all the cancers that have their onset in white blood cells (Leuk means white and emia derives from the word blood in Greek). The only difference between B-cell lymphoma and B-cell leukemia is that leukemia arises in the bloodstream. Here, one subtype of leukemia is described because of the pathophysiological role of Rap, namely T-cell and B-cell Acute Lymphoblastic Leukemia (T-ALL and B-ALL). Acute lymphoblastic leukemia’s undergo the same sort malignant transformation as all cancers, like described before with one specific mutation in NOTCH, which is constitutively active. T-ALL has a prevalence of 10 percent in children and 25 percent in adults (Vlierberghe van P. and Adolfo F., 2012). In this review, we describe a potential role of Rap in migration and tissue colonization in metastasis of leukemia, resulting in a potential drug target to inhibit invasion and metastasis. 


Rap in Leukemia (tissue colonization of cancer cells)

It is already described that Rap1 and its GAPs and GEFs are involved in the onset of metastasis in other cell types (Gao L. et al., 2006, Gutmann D. H. et al., 1997 and Yajnik V. et al, 2003). In human breast epithelial cells, Rap1 acts as a central regulator of tissue architecture. The hyper activation of Rap1 has been implicated in both inhibiting and promoting cancer metastasis of epithelial cells (Itoh M. et al., 2007). Also, it has been found that Rap1 effectors Tiam1/Vav2 are involved in cell transformation in breast and colon under influence of the proto-oncogene Src. Thus, constitutively active Src ensures cancer using the Tiam1/Vav2-Rac signaling pathway, because of cell stress and deformation (Servitja J. M. et al.,  2003). If Tiam1/Vav2 induce cancer under influence of Src, we speculated that this is also possible for Tiam/Vav2 as effectors of Rap1. The reduction of Rap activity showed reduced incidence on developing malignancies, despite the abnormal genomic stability (Itoh M. et al., 2007). But the statements about the reduction of Rap1 activity are ambiguous. In 2012, Banerjee R. et al., have made a model in which activation of Rap1GAP, which inactivates Rap1, reduces incidence of pancreatic cancers, thyroid cancers, and melanomas.
	As Rap is responsible for many functions that involve the adhesion and migration of immune cells, Rap proteins may also play an important role in the tissue invasion of B-, and T-lymphocyte and their cell lineage derived leukemias. In the immune system, promotion of Rap was found involved in metastasis of a more closely related cancer type, namely B-cell lymphomas. The only difference between B-cell lymphoma and B-cell leukemia is that leukemia arises in the bloodstream, so probably these two cancer types develop and react the same. Lin K. B. L. et al. suggested in 2010a that based on these findings, Rap could be a used as a novel drug target to prevent tumor metastasis. It was already proven in vitro that blocking Rap resulted in a reduced intra and extravasation of B-cell lymphoma cells (Shimonaka M. et al., 2003), but now it is also presented in vivo (Lin K. B. L. et al. 2010a). 
	The role of Rap in the pathophysiology of several types of lymphoma and leukemias, occurs through the dysfunction of integrins. To date, inhibition of Rap activity is linked to decreased invasion of cancerous immune cells. In the development of chronic lymphocytic leukemia Rap1 activation is diminished, due to a defect in chemokine-dependent GTP loading. Three different GEFs were tested in the leukemia cell line and Rap, and thereby integrins, was less activated, which means that the problem lies at the level of the GTPase. This is also shown in the case of B-cell lymphomas. Impaired activation of Rap showed less tumor formation in organs where B-cell lymphocytes normally would metastasize to, like the liver (Till K. J. et al., 2008).
	Indeed, it has been described that inhibition of Rap1a and Rap1b causes less leukemic tissue invasion, by regulating ICAM adhesion, than the wild-type leukemic cells (Infante E. et al., 2011). They have shown that statins inhibit Rap1 activity and thereby reduce tissue invasion in leukemia disease. Specifically, statins inhibit the production of farnesyl and geranylgeranyl Isoprenoid, which are posttranslational attached to Rap1. With this modification Rap1 is able to anchor to the plasma membrane. Without this localization, Rap1 can be considered inactive. For T-cell Acute Lymphoblastic Leukemia (T-ALL) (but probably also for the B-cell leukemia) this indicates that Rap1 is required for the adhesion and migration and could be a potential drug target in leukemia. 
	It has also been proven that there consists a positive selection procedure for tumor cells that are capable of reactivating Rap1 (Lin K. B. L. et al., 2010b). In cells of an aggressive large B-cell lymphoma, Rap1 was blocked by adding a specific Rap1GAP. At first, tumor formation was inhibited but, strikingly, it occurred that positive selection took place for the tumor cells that were able to down regulate the RapGAP again. This indicates that activation of Rap provides a selective advantage of tumor cells, potentially by aiding tissue invasion and metastasis. If tumor cells are able to actively switch between upregulation and downregulation of Rap1 activity, metastasis can be controlled. Metastasis may occur via Rap1 promoting the attachment and transmigration of migrating leukemic cells, allowing them to become stuck within tissues. After controlled deactivation of Rap1, tumor cells  are not attached to the tissue anymore, but are freely to start a new tumor. Indeed, in the progressions of B-cell lymphoma to B-cell leukemia the B-cell lymphoma contains a higher concentration of inter alia Rap1-induced active ICAM-1 than the B-cell leukemia cells (Feng H. et al., 2010) This means that during this progression that Rap1-induced ICAM-1 activation is switched. Presumably, for efficient transmigration positive as well as negative regulation of Rap1 are needed, therefore, a switch in Rap activation has to take place. 






















Conclusion and Discussion; Rap1 is a potential drug target in tissue colonizing leukemia

We considered Rap1 as a specific good drug target for leukemia because this disease contains already motile immune cells. Based on this, it should also be drug target in other cancers, but less efficient. In the search of Rap1 as a potential drug target to counter or at least inhibit leukemic metastasis, we found that elaboration of this concept could go two ways. This includes an inhibitory drug or one that will activate Rap. This is based on the discovery that inducing inactivation of Rap1 will probably result in tumor cells that are stuck in the bloodstream and that overstimulation of Rap1 will stay attached at the edges of endothelial cells, because of the strong integrin bonds. Somehow leukemic and lymphoma cells have to find a way to regulate Rap1 for its own use. It has already been described that tumors select for cells, that are capable of reactivating Rap1 after a induced inhibition (Lin K. B. L. et al., 2010b). We will discuss points from both views here as plausible drug targets.
	Rap1 inhibition is potentially a good mechanism to prevent the leukemic cell to escape the bloodstream. As described, Rap1 is a main player in migration of any cell line, so we speculated that this could have a potentially great effect. Arise of the cancer itself is maybe also a little bit inhibited, because of Rap1 involvement in the cell cycle. So, preferably With this approach, but also in the case of a drug that causes over activation of Rap1, specificity of the drug to the leukemic cells and the added side effects can be decisive for choosing between typical drugs. A highly specific drug is difficult to produce, thus we have to concentrate on the side effects. An advantage is that the bloodstream is relatively easily to access to filter the leukemic cells from the blood. The possible side effects of an inhibitory drug are that healthy immune cells will also get stuck in the bloodstream and the attack of pathogenic intruders is diminished. 
	With a promotional approach a drug must have an activating effect on Rap1. This will probably lead to activation of Integrins and the formation of cell-cell junctions, like described. By this, leukemic immune cells are more strongly attached to the epithelial cell layer, using the activated integrins and their epithelial counter parts. At first, this seems a normal process in the extravasation of immune cells, but when Rap1 is over activated cells will not detach again at the tissue or organ site of the endothelial. The positive part of this is that leukemic cells are inhibited in invasion, but on the other hand leukemic cells could start a new tumor right at the spot of their attachment to the endothelial. Also, as with the potential inhibitory drug, also this drug has side effects concerning healthy immune cells targeting a tissue or organ infection. They will not be able to reach the site of infection when Rap1 is overactivated in these cells. Moreover, Rap1 is positively regulating the cell cycle. So, overactivation of Rap1 could also enhance tumor progression. Thus, based on these speculations we lean towards the idea of developing a drug, which rather inhibit Rap1 activation.
	Here, we want to discuss the properties of the hypothetical drug. Endogenous pathways of Rap1 could be altered. Specific Rap1GAPs and Rap1GEFs are especially nice regulators to add as regulators of Rap1. Rap1GAP can be deployed as an inhibitory drug and Rap1GEF as a stimulating drug of Rap1 activity. This can be achieved in two ways. First, the GAP and GEF proteins can be directly given to the patient or a drug can be used that targets the GAPs and GEFs, which activates them. We considered this as a good agent, while these are humanized proteins that are specific binders to the Rap1 protein. If these proteins can be made specific for fast replicating cells, which leukemic cells are, GAPs and GEFs are probably a solution against metastasizing leukemic cells.
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Figure 1. Overview of Rap1 regulation pathways. The RapGEFs are depicted in pink, the RapGAPs in green and the effectors of Rap in yellow. Most of the GEFs are activated by activated Tyrosine Kinase Receptors (RTKs) and effectors are directly or indirectly involved in cell-cell adhesion or movement via Integrins and cadherins interconnected with actin (Bos J. L. 2005).

Figure 2. Afadin acts as an scaffold protein between Nectins of the adherence junctions and the actin skeleton. This can be set up directly via the Afadin actin binding domain or indirectly by Afadin interaction with the actin binding proteins LMO7 and ADIP (Ebnett K., 2008).

Figure 5. Activation of Integrin LFA-1 by RAPL and RIAM under influence of Rap1-GTP. Chemokines activate the T-cell receptor, which induces ultimately activation of Rap1. By activation of the intracellular domain of LFA-1, conformational changes take place in the extracellular domain. The changes include extension of the protein, so it easily able to interact with ICAM1 molecules on the endothelial cells.    (Zhang Y. and Wang H., 2012).

Figure 7. Endogenous pathways involved in the arise of B-, and T-cell leukemia. In red the leukemia-specific (proto) oncogenes and tumor-supressor genes are depicted. One of them is Rap, which is important in the involvement of lymphocyte development. In T-lymphocytes, Rap ensures a proper expression of the T-cell receptors for the positive selection, needed for survival. Also for B-lymphocytes Rap is important for survival and proliferation. Additionally, Rap ensures B-ell receptor editing in order to select for the B-cells that are not auto-reactive (Minato N., 2009).

Figure 6. Summarizing, Rap1 plays an important role in several major processes in motility; Diapedesis, spreading adhesion and migration. These processes are all facilitated by  actin dynamics. The different Rap1 effectors take care of these functions.  (Lin K. B. L. et al., 2010).

Figure 3. Schematic overview of the functions of RIAM. Binding of proteins to the scaffold RIAM, activates several pathways which function within cell movement and adhesion processes. Both Profilin and ENA/VASP proteins act on actin polymerization, while ADAP and Talin activate TCR-dependent integrin activation and β1/β2 integrin activation, respectively. 

Figure 4. Focal adhesion structure formation under influence of RIAM.  Talin is directly bound by RIAM and translocated to plasma membrane, while Paxillin is indirectly is activated by the RIAM-induced ERK-MAP kinase pathway. Together with Integrins, these proteins form focal adhesions (www.SABiosciences.com).
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